HAE vs LNC · P/E 35, rev $1.33B vs P/E 4.9, rev $9.85B
Haemonetics Corporation (HAE) versus Lincoln National Corporation (LNC) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Latest reported LNC revenue for 2026-06-30 was $9.85B. Net income was $1.16B. Revenue was up 85.6% from 2026-03-31 to 2026-06-30. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
Not investment advice. Open the HAE and LNC stock pages for the full models.
Not investment advice.